Welcome to Global Cancer News

- an online media resource, providing you with the latest news in the areas of colorectal cancer, non-small cell lung cancer, and head and neck cancer. You can access comprehensive press kits with everything you need, including an extensive visual and video library, mode of action animations, filmed interviews with leading specialists, disease and clinical information and congress data, to further your knowledge and understanding of these cancer types.
User name  
Password  
  Register



12th World Congress on Gastrointestinal Cancer

30 June – 3 July 2010

Barcelona, Spain


The 12th World Congress on Gastro­intestinal Cancer was held in Barcelona, Spain on 30 June – 3 July 2010. The Congress aims to update gastrointestinal experts from across the globe on the latest updates and advances in the treatment of gastrointestinal cancers.
Merck Serono presented several Erbitux studies at WCGIC this year. Please click on the links below to learn more about the data that was presented as well as other information on colorectal cancer.
Merck Serono press releases
Merck Serono fact sheets
New Virtual Media Briefing with Professor Fortunato Ciardiello
Official WCGIC website





 

The ASCO® 2010

Annual Meeting took place in
Chicago, Illinois, US
from Friday 4 – Tuesday 8 June.


Merck Serono Oncology is focused on developing novel cancer therapies that provide beneficial therapeutic outcomes and create new options for cancer patients.Their continued research and development in this area mirrored the theme of this years ASCO® Annual Meeting, ‘Advancing Quality through Innovation’.
Several Merck Serono treatments were featured at ASCO® this year. We invite you to visit the resources below to learn more about the data that was presented as well as other resources to help you learn more about the latest innovations in research, quality, practice and technology in cancer today.
Merck Serono press releases
Merck Serono fact sheets
Erbitux Virtual Media Briefing
Expert videos
Official ASCO® website


Virtual Media Briefing – Professor Ciardiello:

KRAS testing: The future of mCRC management


New survey data, published at ASCO 2010 and WCGIC 2010, have revealed a significant increase in awareness and usage of KRAS testing in the treatment of metastatic colorectal cancer (mCRC).
These virtual media briefings presented by lead author Professor Fortunato Ciardiello provide an overview of the new data as well as an engaging and insightful snapshot of how KRAS testing and personalized therapies are changing the landscape of mCRC management.
Virtual Media Briefing
 

Hot Topic - Prof Vermorken:

Head and neck cancer – current perspectives on optimal treatment and patient management


Introduction to head and neck cancer
Head and neck cancer is a broad term that covers a range of tumors that occur in the epithelial cells of tissues or organs in the head and neck region, including the oral cavity, pharynx, larynx and nasal cavities, amongst others.
More than 90% of head and neck cancers begin in the flat ‘squamous’ cells that line the surfaces in the head and neck area and are therefore termed ‘squamous cell carcinomas of the head and neck’ (SCCHN) (UPMC Cancer Centers, accessed 2009). Head and neck cancer is the sixth most  ..... read more
Download full article

Patient Group Viewpoints


Merck Serono recognises the importance of communicating effectively with patients. We are working with key stakeholders to determine how best to communicate to patients about personalized therapies and biomarkers. In doing so, we aim to gain expert guidance on what information patients need in order to gain a practical understanding of the treatment options available to them.
Filmed interviews

 

World Cancer Day

4 February 2010


Each year on 4 February, the International Union Against Cancer (UICC) is joined by the World Health Organisation (WHO) to raise awareness of cancer and to encou­rage its prevention, detection and treat­ment.
Cancer is a leading cause of death around the world. The UICC estimates that each year, over 12 million people receive a can­cer diagnosis and 7.6 million die of the disease.
This February, UICC launches the campaign “Cancer can be prevented too”, focusing on how the risk of developing cancer can significantly be reduced through simple measures. For more information on World Cancer Day and anticancer activity in February, please visit the links below.
World Cancer Declaration
SIGN HERE

UICC Website

Visual and video library

Download a comprehensive range of visuals and videos.
Click here

The KRAS Test

Get more information about the KRAS test procedure in this video. Click here

Erbitux - Mode of Action

Get more information about Erbitux mode of action in this new video. Click here



This website is intended for use by
non-US residents only. 		Legal Disclaimer
Merck Serono Homepage
© 2010 Merck Serono 		About Merck Serono
About Merck